MIR17HG and endometrial cancer: Wang et al. (2020) showed that SCARNA9 is associated with the prognosis of patients with endometrial cancer. Xu et al. (2019) suggested that MIR17HG is an immune-related lncRNA, as it was upregulated in CRC tissues compared with normal tissues. Moreover, MIR17HG also contributed to tumorigenesis and metastasis in CRC cells both in vitro and in vivo. Cao et al. (2019) also showed that MIR17HG is upregulated in glioma tissues and cell lines and that downregulation of MIR17HG is related to inhibition of glioma cell progression.